Jessica M Wilson, Catherine Lumley, Xianming Tan, Colette Shen, Andrew Coniglio, Mark Weissler, Wendell G Yarbrough, Trevor Hackman, Jeffrey Blumberg, Adam Zanation, Brian Thorp, Samip N Patel, Bhishamjit S Chera
{"title":"Clinical Outcomes of Patients With pT1-T2N0 Oral Tongue Squamous Cell Carcinoma.","authors":"Jessica M Wilson, Catherine Lumley, Xianming Tan, Colette Shen, Andrew Coniglio, Mark Weissler, Wendell G Yarbrough, Trevor Hackman, Jeffrey Blumberg, Adam Zanation, Brian Thorp, Samip N Patel, Bhishamjit S Chera","doi":"10.1097/COC.0000000000000806","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to evaluate the clinical outcomes in a cohort of patients with early-stage oral tongue squamous cell carcinoma (OTSCC).</p><p><strong>Materials and methods: </strong>We conducted a retrospective analysis of patients with pT1-T2N0 (American Joint Committee on Cancer [AJCC] seventh edition) OTSCC treated from 2000 to 2018. Two-year actuarial rates of local regional control, cancer-specific survival, and overall survival were calculated for the entire cohort and patients with/without adjuvant radiation.</p><p><strong>Results: </strong>Ninety-six patients met the criteria with a median follow-up of 4 years; 14 had adjuvant radiation, while 82 had surgery alone. Two-year local regional control was 82.7% (75.4% to 90.8%) for the entire cohort, 84.9% (77.8% to 93.2%) for surgery only, and 70.7% (50.2% to 99.6%) for patients with adjuvant radiation. Two-year progression-free survival was 82.7% (75.3% to 90.8%). Of the 20 patients with recurrence, 11 (55%) were successfully salvaged.</p><p><strong>Conclusion: </strong>Local regional recurrence remains modest in early-stage OTSCC, but salvage is possible with high survival rates.</p><p><strong>Level of evidence: </strong>Level III-retrospective cohort study.</p>","PeriodicalId":501816,"journal":{"name":"American Journal of Clinical Oncology","volume":" ","pages":"200-205"},"PeriodicalIF":0.0000,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Clinical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/COC.0000000000000806","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Objective: The objective of this study was to evaluate the clinical outcomes in a cohort of patients with early-stage oral tongue squamous cell carcinoma (OTSCC).
Materials and methods: We conducted a retrospective analysis of patients with pT1-T2N0 (American Joint Committee on Cancer [AJCC] seventh edition) OTSCC treated from 2000 to 2018. Two-year actuarial rates of local regional control, cancer-specific survival, and overall survival were calculated for the entire cohort and patients with/without adjuvant radiation.
Results: Ninety-six patients met the criteria with a median follow-up of 4 years; 14 had adjuvant radiation, while 82 had surgery alone. Two-year local regional control was 82.7% (75.4% to 90.8%) for the entire cohort, 84.9% (77.8% to 93.2%) for surgery only, and 70.7% (50.2% to 99.6%) for patients with adjuvant radiation. Two-year progression-free survival was 82.7% (75.3% to 90.8%). Of the 20 patients with recurrence, 11 (55%) were successfully salvaged.
Conclusion: Local regional recurrence remains modest in early-stage OTSCC, but salvage is possible with high survival rates.
Level of evidence: Level III-retrospective cohort study.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
